Shell Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,254
Closed -$854K 1288
2023
Q2
$854K Sell
20,254
-115
-0.6% -$4.65K 0.03% 407
2023
Q1
$726K Buy
20,369
+13,054
+178% +$474K 0.03% 440
2022
Q4
$268K Sell
7,315
-1,541
-17% -$60.9K 0.01% 821
2022
Q3
$418K Sell
8,856
-2,334
-21% -$151K 0.02% 662
2022
Q2
$802K Buy
11,190
+1,701
+18% +$124K 0.02% 492
2022
Q1
$768K Sell
9,489
-1,405
-13% -$119K 0.02% 606
2021
Q4
$1.12M Buy
10,894
+4,086
+60% +$392K 0.02% 520
2021
Q3
$596K Buy
6,808
+3,748
+122% +$339K 0.01% 789
2021
Q2
$274K Buy
3,060
+170
+6% +$14.4K 0.01% 1142
2021
Q1
$219K Buy
+2,890
New +$218K ﹤0.01% 1124

Other funds holding SYNH

Shell Asset Management's SYNH Position: Q3 2023 in Review

Shell Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 20,254 shares — an estimated $854K sold.

Shell Asset Management first reported a position in SYNH in Q1 2021 and held it in 10 quarters. The position peaked at $1.12M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Shell Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Shell Asset Management sold 20,254 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $854K.
  • Shell Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 10 quarters.
  • Shell Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $1.12M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Shell Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.